Unnamed: 0,title,date,stock,sentiment
1277720.0,"TherapeuticsMD Director Bisaro Buys 50,000 Shares @$1.14/Share",2020-06-08 16:13:00-04:00,TXMD,positive
1277721.0,TherapeuticsMD Announces James D'Arecca CFO Following Retirement of Current CFO,2020-06-01 06:52:00-04:00,TXMD,neutral
1277722.0,20 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-22 07:47:00-04:00,TXMD,neutral
1277723.0,"Benzinga's Top Upgrades, Downgrades For May 19, 2020",2020-05-19 10:33:00-04:00,TXMD,positive
1277724.0,JP Morgan Downgrades TherapeuticsMD to Neutral,2020-05-19 05:48:00-04:00,TXMD,positive
1277725.0,20 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-05-14 07:40:00-04:00,TXMD,neutral
1277726.0,"H.C. Wainwright Reiterates Buy on TherapeuticsMD, Lowers Price Target to $5",2020-05-07 08:47:00-04:00,TXMD,negative
1277727.0,TherapeuticsMD shares are trading lower after the company reported worse-than-expected Q1 EPS results.,2020-05-06 12:18:00-04:00,TXMD,neutral
1277728.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,TXMD,positive
1277729.0,19 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-05-06 07:36:00-04:00,TXMD,neutral
1277730.0,33 Stocks Moving in Wednesday's Pre-Market Session,2020-05-06 07:15:00-04:00,TXMD,neutral
1277731.0,TherapeuticsMD: Q1 Earnings Insights,2020-05-06 07:15:00-04:00,TXMD,neutral
1277732.0,"TherapeuticsMD shares are trading higher after the company reported better-than-expected Q1 sales results. UPDATE: Shares have since reversed, now lower.",2020-05-06 06:57:00-04:00,TXMD,positive
1277733.0,"TherapeuticsMD Q1 EPS $(0.210) Misses $(0.190) Estimate, Sales $12.300M Beat $11.300M Estimate",2020-05-06 06:52:00-04:00,TXMD,negative
1277734.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,TXMD,neutral
1277735.0,TherapeuticsMD Option Alert: Jun 19 $2 Calls Sweep (3) near the Ask: 357 @ $0.551 vs 9366 OI; Earnings 5/6 Before Open Ref=$2.06,2020-04-30 09:32:00-04:00,TXMD,positive
1277736.0,108 Biggest Movers From Yesterday,2020-04-30 05:30:00-04:00,TXMD,neutral
1277737.0,82 Stocks Moving In Wednesday's Mid-Day Session,2020-04-29 12:50:00-04:00,TXMD,neutral
1277738.0,16 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-04-29 07:35:00-04:00,TXMD,neutral
1277739.0,TherapeuticsMD shares are trading higher after the company announced it has been issued the first Orange Book listable US Patent for ANNOVERA.,2020-04-29 07:29:00-04:00,TXMD,positive
1277740.0,TherapeuticsMD Announces Issuance Of First Orange Book Listable US Patent For ANNOVERA,2020-04-29 06:50:00-04:00,TXMD,neutral
1277741.0,"Stifel Maintains Buy on TherapeuticsMD, Raises Price Target to $15",2020-04-16 11:06:00-04:00,TXMD,neutral
1277742.0,"The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant",2020-04-16 08:09:00-04:00,TXMD,neutral
1277743.0,"The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US",2020-04-15 08:03:00-04:00,TXMD,neutral
1277744.0,"The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO",2020-04-08 07:53:00-04:00,TXMD,neutral
1277745.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus package boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 10:58:00-04:00,TXMD,positive
1277746.0,"The Daily Biotech Pulse: Sanofi-Translate Bio Join Hands For Coronavirus Vaccine, TherapeuticsMD Suspends Guidance",2020-03-27 08:02:00-04:00,TXMD,positive
1277747.0,TherapeuticsMD Sees Q1 Sales To Be More Than $11M,2020-03-26 16:07:00-04:00,TXMD,neutral
1277748.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,TXMD,negative
1277749.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,TXMD,neutral
1277750.0,Stocks That Hit 52-Week Lows On Wednesday,2020-03-18 11:37:00-04:00,TXMD,negative
1277751.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,TXMD,positive
1277752.0,Shares of several companies in the healthcare space are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 10:18:00-04:00,TXMD,negative
1277753.0,TherapeuticsMD Says Business Operations Not Impacted by COVID-19,2020-03-16 06:17:00-04:00,TXMD,neutral
1277754.0,TherapeuticsMD Says Does Not Anticipate a Shortage of Its Products Due to Covid-19 at This Time,2020-03-16 06:04:00-04:00,TXMD,positive
1277755.0,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",2020-03-13 07:52:00-04:00,TXMD,negative
1277756.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,TXMD,negative
1277757.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,TXMD,negative
1277758.0,Shares of several healthcare-related companies are trading higher after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.,2020-03-04 07:16:00-05:00,TXMD,positive
1277759.0,"The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More",2020-03-03 07:51:00-05:00,TXMD,positive
1277760.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,TXMD,negative
1277761.0,50 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-02-28 08:34:00-05:00,TXMD,neutral
1277762.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,TXMD,neutral
1277763.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,TXMD,negative
1277764.0,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",2020-02-27 07:35:00-05:00,TXMD,positive
1277765.0,Shares of several healthcare and biotech companies are trading lower amid continued spread of coronavirus including notable upticks in Iran and Italy. NOTE: The virus has raised fear of a global economic slowdown.,2020-02-24 08:37:00-05:00,TXMD,negative
1277766.0,"H.C. Wainwright Maintains Buy on TherapeuticsMD, Lowers Price Target to $6",2020-02-21 07:18:00-05:00,TXMD,negative
1277767.0,95 Biggest Movers From Yesterday,2020-02-21 05:12:00-05:00,TXMD,neutral
1277768.0,71 Stocks Moving In Thursday's Mid-Day Session,2020-02-20 12:16:00-05:00,TXMD,neutral
1277769.0,TherapeuticsMD shares are trading lower after the company reported Q4 earnings results.,2020-02-20 10:58:00-05:00,TXMD,neutral
1277770.0,22 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-02-20 07:56:00-05:00,TXMD,neutral
1277771.0,50 Stocks Moving in Thursday's Pre-Market Session,2020-02-20 07:30:00-05:00,TXMD,neutral
1277772.0,TherapeuticsMD Sees FY20 Net Sales $90M-$110M,2020-02-20 07:24:00-05:00,TXMD,neutral
1277773.0,"TherapeuticsMD Q4 EPS $(0.19), Inline, Sales $15.902M Beat $12.83M Estimate",2020-02-20 07:24:00-05:00,TXMD,neutral
1277774.0,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",2020-02-20 07:06:00-05:00,TXMD,negative
1277775.0,"The Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA Decisions",2020-02-16 15:03:00-05:00,TXMD,positive
1277776.0,"TherapeuticsMD Reports Expanded Access To ANNOVERA With Afaxys, No Terms Disclosed",2020-02-13 06:32:00-05:00,TXMD,negative
1277777.0,90 Biggest Movers From Yesterday,2020-02-06 05:15:00-05:00,TXMD,neutral
1277778.0,68 Stocks Moving In Wednesday's Mid-Day Session,2020-02-05 12:16:00-05:00,TXMD,neutral
1277779.0,TherapeuticsMD shares are trading higher on a rebound amid coronavirus fears.,2020-02-05 09:14:00-05:00,TXMD,negative
1277780.0,A Peek Into The Markets: US Stock Futures Gain Ahead Of Manufacturing Data,2020-02-03 06:48:00-05:00,TXMD,positive
1277781.0,TherapeuticsMD Submits New Drug Application to the FDA for Lower Dose BIJUVA,2020-02-03 06:32:00-05:00,TXMD,negative
1277782.0,14 Drug Manufacturers—Specialty & Generic Stocks Moving In Thursday's Session,2020-01-23 12:52:00-05:00,TXMD,neutral
1277783.0,18 Drug Manufacturers—Specialty & Generic Stocks Moving In Wednesday's Session,2020-01-22 13:28:00-05:00,TXMD,neutral
1277784.0,82 Biggest Movers From Yesterday,2020-01-22 04:18:00-05:00,TXMD,neutral
1277785.0,55 Stocks Moving In Tuesday's Mid-Day Session,2020-01-21 12:14:00-05:00,TXMD,neutral
1277786.0,TherapeuticsMD shares are trading higher. Not seeing any news to justify the price action.,2020-01-21 11:18:00-05:00,TXMD,positive
1277787.0,TherapeuticsMD shares are trading higher on seemingly no company-specific news. NOTE: U.S. equities are trading higher ahead of today's signing of the U.S.-China phase one trade deal.,2020-01-15 11:41:00-05:00,TXMD,neutral
1277788.0,TherapeuticsMD shares are trading higher. Not currently seeing any company-specific news.,2019-12-23 11:50:00-05:00,TXMD,positive
1277789.0,36 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-12-19 08:28:00-05:00,TXMD,neutral
1277790.0,64 Biggest Movers From Yesterday,2019-12-19 05:03:00-05:00,TXMD,neutral
1277791.0,40 Stocks Moving In Wednesday's Mid-Day Session,2019-12-18 12:04:00-05:00,TXMD,neutral
1277792.0,74 Biggest Movers From Yesterday,2019-12-17 05:35:00-05:00,TXMD,neutral
1277793.0,TherapeuticsMD shares are trading higher. Not seeing any news to justify the price action. NOTE: Penny stocks can have volatile price action with no catalyst.,2019-12-16 13:20:00-05:00,TXMD,neutral
1277794.0,"Knight Therapeutics, TherapeuticsMD Reports Knight's New Drug Submission For BIJUVA Accepted For Review By Health Canada",2019-11-26 07:39:00-05:00,TXMD,positive
1277795.0,TherapeuticsMD shares are trading lower on seemingly no company-specific news. The stock had a breakout above the $2.75 resistance level and traded lower.,2019-11-25 15:11:00-05:00,TXMD,negative
1277796.0,30 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-15 08:14:00-05:00,TXMD,neutral
1277797.0,94 Biggest Movers From Yesterday,2019-11-08 06:01:00-05:00,TXMD,neutral
1277798.0,75 Stocks Moving In Thursday's Mid-Day Session,2019-11-07 12:19:00-05:00,TXMD,neutral
1277799.0,TherapeuticsMD shares are trading higher following Q3 results.,2019-11-07 08:54:00-05:00,TXMD,positive
1277800.0,23 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-11-07 08:04:00-05:00,TXMD,neutral
1277801.0,30 Stocks Moving in Thursday's Pre-Market Session,2019-11-07 07:58:00-05:00,TXMD,neutral
1277802.0,"The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs",2019-11-07 07:18:00-05:00,TXMD,negative
1277803.0,"TherapeuticsMD Q3 EPS $(0.13) Up From $(0.16) YoY, Sales $23.72M Up From $3.473M YoY",2019-11-06 16:53:00-05:00,TXMD,neutral
1277804.0,15 Stocks Moving in Thursday's Pre-Market Session,2019-10-31 09:32:00-04:00,TXMD,neutral
1277805.0,Knight And TherapeuticsMD Announce Filing Of New Drug Submission For Joyesta In Canada,2019-10-30 17:40:00-04:00,TXMD,neutral
1277806.0,TherapeuticsMD shares are trading lower after the company announced a 26 million share common stock offering at $2.75 per share.,2019-10-25 09:02:00-04:00,TXMD,positive
1277807.0,TherapeuticsMD Prices 26M Share Offering of Common Stock @$2.75/Share,2019-10-25 03:55:00-04:00,TXMD,positive
1277808.0,Mid-Afternoon Market Update: Oil Prices Hover At One-Month High; Technology Stocks Spike Higher,2019-10-24 14:29:00-04:00,TXMD,neutral
1277809.0,21 Stocks Moving In Thursday's Mid-Day Session,2019-10-24 13:21:00-04:00,TXMD,neutral
1277810.0,Mid-Day Market Update: Nokia Falls Following Guidance Cut; CIM Commercial Trust Shares Climb,2019-10-24 12:32:00-04:00,TXMD,positive
1277811.0,Mid-Morning Market Update: Markets Move Higher; Twitter Tumbles On Missed Q3 Earnings,2019-10-24 11:07:00-04:00,TXMD,negative
1277812.0,TherapeuticsMD shares are trading lower after the company announced a proposed underwritten public offering of 22 million shares of common stock.,2019-10-24 07:53:00-04:00,TXMD,positive
1277813.0,"The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise",2019-10-24 07:36:00-04:00,TXMD,neutral
1277814.0,TherapeuticsMD shares are trading lower after the company announced a proposed underwritten public offering of 22 million shares of common stock.,2019-10-23 16:48:00-04:00,TXMD,positive
1277815.0,"TherapeuticsMD Announces Proposed Underwritten Public Offering Of 22 Million Shares Of Common Stock, No Terms Disclosed",2019-10-23 16:48:00-04:00,TXMD,neutral
1277816.0,"TherapeuticsMD Sees Q3 Sales From Prescription Vitamin Business $2.5M-$2.6M, Sales From IMVEXXY, BIJUVA, ANNOVERA $5.32B-$5.7B",2019-10-23 16:45:00-04:00,TXMD,positive
1277817.0,TherapeuticsMD Reports Presentations On ANNOVERA At American Society for Reproductive Medicine,2019-10-11 07:02:00-04:00,TXMD,neutral
1277818.0,"Shares of several healthcare stocks are trading lower in sympathy with the overall market after the Institute for Supply Management said U.S. manufacturing activity shrunk to its lowest level since June 2009, adding fears of an economic slowdown.",2019-10-01 13:02:00-04:00,TXMD,negative
1277819.0,55 Biggest Movers From Yesterday,2019-09-26 04:34:00-04:00,TXMD,neutral
1277820.0,34 Stocks Moving In Wednesday's Mid-Day Session,2019-09-25 12:02:00-04:00,TXMD,neutral
1277821.0,TherapeuticsMD shares are trading higher after the company reported it sees Q3 total net revenue to be $6.8 million to $9 million.,2019-09-25 10:38:00-04:00,TXMD,positive
1277822.0,TherapeuticsMD Sees Q3 Total Net Revenue $6.8M-$9M,2019-09-25 07:00:00-04:00,TXMD,neutral
1277823.0,25 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-08-21 08:48:00-04:00,TXMD,neutral
1277824.0,"SEC Says It Charges TherapeuticsMD With Regulatory Violations; Says Co.  Shared Material, Nonpublic Information With Sell-Side Research Analysts Without Disclosing The Information To The Public, Co. Has Agreed To Pay $200K Fine",2019-08-20 10:13:00-04:00,TXMD,negative
1277825.0,75 Biggest Movers From Yesterday,2019-08-16 05:16:00-04:00,TXMD,neutral
1277826.0,46 Stocks Moving In Thursday's Mid-Day Session,2019-08-15 12:44:00-04:00,TXMD,neutral
1277827.0,"Shares of several healthcare companies are trading lower in sympathy with the overall market after the spread between the 2-year and 10-year yield curve inverted for the first time since 2007, potentially signaling an oncoming recession.",2019-08-14 11:17:00-04:00,TXMD,negative
1277828.0,17 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-08-12 08:30:00-04:00,TXMD,neutral
1277829.0,28 Stocks Moving In Monday's Pre-Market Session,2019-08-12 08:14:00-04:00,TXMD,neutral
1277830.0,90 Biggest Movers From Friday,2019-08-12 05:49:00-04:00,TXMD,neutral
1277831.0,75 Stocks Moving In Friday's Mid-Day Session,2019-08-09 14:06:00-04:00,TXMD,neutral
1277832.0,TherapeuticsMD shares are higher on continued momentum after the company reported better-than-expected Q2 EPS and sales results on Tuesday.﻿,2019-08-09 12:47:00-04:00,TXMD,positive
1277833.0,31 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-09 09:00:00-04:00,TXMD,neutral
1277834.0,52 Stocks Moving In Friday's Pre-Market Session,2019-08-09 08:30:00-04:00,TXMD,neutral
1277835.0,110 Biggest Movers From Yesterday,2019-08-09 05:15:00-04:00,TXMD,neutral
1277836.0,50 Healthcare Stocks Moving In Thursday's After-Market Session,2019-08-08 21:56:00-04:00,TXMD,neutral
1277837.0,TherapeuticsMD shares are higher on continued momentum after the company reported better-than-expected Q2 EPS and sales results.,2019-08-08 13:30:00-04:00,TXMD,positive
1277838.0,90 Stocks Moving In Thursday's Mid-Day Session,2019-08-08 12:50:00-04:00,TXMD,neutral
1277839.0,42 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-08-07 21:24:00-04:00,TXMD,neutral
1277840.0,TherapeuticsMD shares are trading higher after the company reported better-than-expected Q2 sales results.,2019-08-07 12:41:00-04:00,TXMD,positive
1277841.0,"The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout",2019-08-07 07:34:00-04:00,TXMD,neutral
1277842.0,ThereapeuticsMD shares are trading higher after the company reported better-than-expected Q2 sales results.,2019-08-06 17:22:00-04:00,TXMD,positive
1277843.0,"TherapeuticsMD Q2 EPS $(0.23) Misses $(0.17) Estimate, Sales $6.079M Beat $5.12M Estimate",2019-08-06 17:02:00-04:00,TXMD,negative
1277844.0,"The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering",2019-08-06 07:22:00-04:00,TXMD,positive
1277845.0,New 52-Week Lows For Monday Morning,2019-08-05 13:16:00-04:00,TXMD,negative
1277846.0,29 Healthcare Stocks Moving In Friday's After-Market Session,2019-08-02 20:51:00-04:00,TXMD,neutral
1277847.0,Stocks That Set New 52-Week Lows Friday Morning,2019-08-02 10:46:00-04:00,TXMD,negative
1277848.0,35 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-07-25 05:55:00-04:00,TXMD,neutral
1277849.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,TXMD,neutral
1277850.0,35 Stocks Moving In Wednesday's Mid-Day Session,2019-06-12 12:54:00-04:00,TXMD,neutral
1277851.0,"The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana",2019-06-12 07:34:00-04:00,TXMD,neutral
1277852.0,"Jim Cramer Shares His Thoughts On TherapeuticsMD, Rite Aid And More",2019-06-12 07:25:00-04:00,TXMD,positive
1277853.0,66 Biggest Movers From Yesterday,2019-06-12 04:44:00-04:00,TXMD,neutral
1277854.0,"UPDATE: TherapeuticsMD Will Receive €14M As Upfront Fee, Is Eligible To Receive Up To €29.5M In Regulatory, Sales Milestone Payments",2019-06-07 07:20:00-04:00,TXMD,neutral
1277855.0,"TherapeuticsMD Reports Exclusive License, Supply Deal To Commercialize BIJUVA, IMVEXXY Outside The US",2019-06-07 07:19:00-04:00,TXMD,positive
1277856.0,30 Stocks Moving In Friday's Mid-Day Session,2019-05-24 13:00:00-04:00,TXMD,neutral
1277857.0,"The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice",2019-05-24 07:44:00-04:00,TXMD,neutral
1277858.0,"The Daily Biotech Pulse: Breakthrough Therapy Designation For Iovance, Guardant Prices Offering, 2 Stocks to Debut",2019-05-23 07:37:00-04:00,TXMD,neutral
1277859.0,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings",2019-05-14 07:42:00-04:00,TXMD,positive
1277860.0,72 Biggest Movers From Yesterday,2019-05-08 06:17:00-04:00,TXMD,neutral
1277861.0,64 Stocks Moving In Tuesday's Mid-Day Session,2019-05-07 12:17:00-04:00,TXMD,neutral
1277862.0,TherapeuticsMD shares are trading lower after the company reported worse-than-expected Q1 sales results.,2019-05-07 09:33:00-04:00,TXMD,neutral
1277863.0,"The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex",2019-05-07 08:20:00-04:00,TXMD,neutral
1277864.0,TherapeuticsMD shares are trading lower after the company reported lower-than-expected Q1 sales results.,2019-05-06 18:32:00-04:00,TXMD,neutral
1277865.0,"TherapeuticsMD Q1 EPS $(0.16) Beats $(0.17) Estimate, Sales $3.947M Miss $5.89M Estimate",2019-05-06 16:46:00-04:00,TXMD,negative
1277866.0,TherapeuticsMD Highlights Presentation Of New Research On How Women's Menopausal Symptoms Affect Men At American College of Obstetricians and Gynecologists 2019 Annual Meeting,2019-05-06 07:08:00-04:00,TXMD,neutral
1277867.0,22 Stocks Moving In Monday's Pre-Market Session,2019-04-29 08:00:00-04:00,TXMD,neutral
1277868.0,TherapeuticsMD Announces Commercial Availability Of BIJUVA In US,2019-04-17 07:06:00-04:00,TXMD,neutral
1277869.0,TherapeuticsMD Signs Binding Commitment Letter For $300 Million Non-Dilutive Term Loan Financing Facility With TPG Sixth Street Partners,2019-04-17 07:06:00-04:00,TXMD,positive
1277870.0,Shares of several drug companies are trading lower. Weakness may be tied to uncertainty over healthcare policy going into the 2020 primaries and Washington's recent efforts to curb prescription drug prices.,2019-04-16 15:34:00-04:00,TXMD,negative
1277871.0,"The Daily Biotech Pulse: BioMarin Slips On Earnings, TherapeuticsMD Posts In-Line Results, Orchard To Present Immunodeficiency Drug Data",2019-02-22 08:50:00-05:00,TXMD,neutral
1277872.0,26 Stocks Moving In Friday's Pre-Market Session,2019-02-22 08:16:00-05:00,TXMD,neutral
1277873.0,"TherapeuticsMD Q4 Adj. EPS $(0.17), Inline, Sales $5.09M Beat $5M Estimate",2019-02-21 17:08:00-05:00,TXMD,neutral
1277874.0,"Jim Cramer Weighs In On Palo Alto, Blackstone And More",2018-12-21 07:18:00-05:00,TXMD,neutral
1277875.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,TXMD,positive
1277876.0,"The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch",2018-12-14 07:47:00-05:00,TXMD,neutral
1277877.0,"The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen",2018-12-13 07:56:00-05:00,TXMD,positive
1277878.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 11, 2018",2018-12-12 11:47:00-05:00,TXMD,negative
1277879.0,"The Daily Biotech Pulse: Legal Victory For Boston Scientific, Alder Gets New CFO, FDA Go-Ahead For BioXcel",2018-12-12 08:07:00-05:00,TXMD,positive
1277880.0,"The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",2018-11-08 08:10:00-05:00,TXMD,negative
1277881.0,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie",2018-11-07 07:50:00-05:00,TXMD,negative
1277882.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,TXMD,neutral
1277883.0,30 Stocks Moving In Monday's Pre-Market Session,2018-10-29 08:25:00-04:00,TXMD,neutral
1277884.0,TherapeuticsMD Announces FDA Approval of TX-001HR: BIJUVA Capsules for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause,2018-10-29 06:02:00-04:00,TXMD,positive
1277885.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs",2018-10-27 10:23:00-04:00,TXMD,neutral
1277886.0,"Jim Cramer Weighs In On BlackRock, JetBlue And More",2018-10-17 07:03:00-04:00,TXMD,neutral
1277887.0,"Jim Cramer Gives His Opinion On Mastercard, Dell Technologies And More",2018-10-09 06:41:00-04:00,TXMD,neutral
1277888.0,"The Daily Biotech Pulse: FDA Nods For Adamis, Eli Lilly, Pfizer; Spero, Obseva Report Positive Trial Results",2018-09-28 08:10:00-04:00,TXMD,positive
1277889.0,TherapeuticsMD Enters Into FDA Label Discussions for TX-001HR,2018-09-27 16:05:00-04:00,TXMD,neutral
1277890.0,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,2018-09-26 16:41:00-04:00,TXMD,neutral
1277891.0,TherapeuticsMD Reports FDA Granted Annovera Marketing Exclusivity As New Chemical Entity,2018-09-20 07:03:00-04:00,TXMD,positive
1277892.0,FDA Approves New Form Of Self-Administered Female Birth Control,2018-08-10 16:09:00-04:00,TXMD,positive
1277893.0,TherapeuticsMD Shares Open For Trade,2018-08-10 15:38:00-04:00,TXMD,positive
1277894.0,TherapeuticsMD Shares To Resume Trade At 3:30 p.m. EDT,2018-08-10 15:19:00-04:00,TXMD,positive
1277895.0,TherapeuticsMD Issues Press Release Confirming FDA Approval Of ANNOVERA For Birth Control,2018-08-10 15:06:00-04:00,TXMD,positive
1277896.0,FDA Approves TherapeuticsMD's Annovera,2018-08-10 14:21:00-04:00,TXMD,positive
1277897.0,BZ NOTE: TherapeuticsMD Has FDA PDUFA Decision Deadline For Segesterone Acetate/Ethinyl Estradiol (Annovera) Friday August 17th,2018-08-10 14:13:00-04:00,TXMD,positive
1277898.0,TherapeuticsMD Halted News Pending,2018-08-10 14:11:00-04:00,TXMD,neutral
1277899.0,TherapeuticsMD Late Wednesday Announced $65.1M Common Stock Offering Priced At $5.10/Share,2018-08-02 10:22:00-04:00,TXMD,neutral
1277900.0,TherapeuticsMD Licenses Population Council's 1-Year Vaginal Contraceptive For $20M Upon FDA Approval and $20M Upon Release of the 1st Commercial Batch,2018-07-31 17:11:00-04:00,TXMD,positive
1277901.0,TherapeuticsMD Announces Proposed $65M Underwritten Public Offering And Concurrent $20M Registered Direct Offering Of Common Stock,2018-07-31 16:40:00-04:00,TXMD,neutral
1277902.0,"Knight Therapeutics And TherapeuticsMD Announce Strategic Partnership; Knight Receives License To TX-004HR And TX-001HR, Agrees To Invest $20M In TherapeuticsMD",2018-07-31 16:13:00-04:00,TXMD,positive
1277903.0,TherapeuticsMD Announces $65M Underwritten Public Offering With Concurrent $20M Registerd Direct Offering To A Strategic Investor of Common Stock,2018-07-31 16:10:00-04:00,TXMD,neutral
1277904.0,"TherapeuticsMD Q2 EPS $(0.15) Misses $(0.12) Estimate, Sales $3.763M Miss $4.25M Estimate",2018-07-30 06:17:00-04:00,TXMD,negative
1277905.0,"JP Morgan Initiates Coverage On TherapeuticsMD with Overweight Rating, Announces $11 Price Target",2018-06-15 07:06:00-04:00,TXMD,neutral
1277906.0,TherapeuticsMD Announces $75M Draw Down Under Term Loan With MidCap Financial,2018-06-07 16:18:00-04:00,TXMD,neutral
1277907.0,"Benzinga's Daily Biotech Pulse: Johnson & Johnson to Dispose Sterilization Products Business, Mixed Results From Protesostasis' Cystic Fibrosis Study",2018-06-07 07:58:00-04:00,TXMD,neutral
1277908.0,"Jefferies 2018 Global Healthcare Conference Continues Today, Presenters Include: TherapeuticsMD, Charles River, OSI Systems, Odonate Therapeutics, Syros, Alnylam, Gilead, and Celgene",2018-06-06 07:29:00-04:00,TXMD,neutral
1277909.0,Thjerapeutics MD Option Alert: Sep 21 $6 Calls at the Bid: 1659 @ $1.0 vs 967 OI; Earnings 8/2 After Close [est] Ref=$6.16,2018-06-05 11:13:00-04:00,TXMD,positive
1277910.0,"The Week Ahead: Apple's Developer Conference In The Spotlight, ASCO Meeting Could Move Biotechs",2018-06-04 12:12:00-04:00,TXMD,neutral
1277911.0,Companies Holding Analyst/Investor Days Today Include New Relic and TherapeuticsMD,2018-06-04 06:51:00-04:00,TXMD,neutral
1277912.0,The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines,2018-06-03 19:27:00-04:00,TXMD,negative
1277913.0,TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY,2018-05-30 09:38:00-04:00,TXMD,positive
1277914.0,TherapeuticsMD Announces FDA Approval Of IMVEXXY — For Real This Time,2018-05-30 09:34:00-04:00,TXMD,positive
1277915.0,20 Stocks Moving In Wednesday's Pre-Market Session,2018-05-30 08:27:00-04:00,TXMD,neutral
1277916.0,A Peek Into The Markets: US Stock Futures Rise Ahead Of Economic Reports,2018-05-30 07:11:00-04:00,TXMD,neutral
1277917.0,TherapeuticsMD Announces FDA Approval Of TX-004HR: IMVEXXY (estradiol vaginal inserts) For Moderate To Severe Dyspareunia Due To Menopause,2018-05-30 06:09:00-04:00,TXMD,positive
1277918.0,"TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXY (estradiol vaginal inserts), the Lowest Dose Vaginal Estrogen Product Approved for the Treatment of Moderate to Severe Dyspareunia, a Symptom of VVA, Due to Menopause",2018-05-30 06:02:00-04:00,TXMD,positive
1277919.0,"The Week Ahead: Retail Earnings, CEO Conference Appearances In Focus",2018-05-29 11:31:00-04:00,TXMD,neutral
1277920.0,REMINDER: TherapeuticsMD Has FDA PDUFA Date Today for TX-004HR,2018-05-29 07:28:00-04:00,TXMD,neutral
1277921.0,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,2018-05-26 11:07:00-04:00,TXMD,neutral
1277922.0,"TherapeuticsMD Shares Resume Trade, Fall To Session Low, Down 0.7%",2018-05-23 13:10:00-04:00,TXMD,neutral
1277923.0,"TherapeuticsMD Says Imvexxy Awaits May PDUFA Date, Doesn't Acknowledge Website Error",2018-05-23 13:08:00-04:00,TXMD,positive
1277924.0,TherapeuticsMD Shares To Resume Trade At 1:10 p.m. EDT,2018-05-23 12:52:00-04:00,TXMD,positive
1277925.0,"TherapeuticsMD Comments On Media Reports Related to TX-004HR, Reiterates FDA PDUFA Date of May 29th, Has Not Been Informed By The FDA Of The Review Status of the NDA",2018-05-23 12:39:00-04:00,TXMD,neutral
1277926.0,TherapeuticsMD Shares Halted News Pending,2018-05-23 11:40:00-04:00,TXMD,positive
1277927.0,TherapeuticsMD Shares Pare Most Gains; Website Imvexxy.com Which Was Previously Circulated As An Indication The Product Was Approved By FDA Is Now Down,2018-05-23 11:36:00-04:00,TXMD,positive
1277928.0,'$TXMD appears to have won approval for its vagina hormone Imvexxy. imvexxy.com',2018-05-23 11:21:00-04:00,TXMD,positive
1277929.0,"TherapeuticsMD Shares Spike Higher, Pullback From High Over $6.10, As Traders Circulate Word Immvexxy.com Website Recently Went Live; Site Shows Imvexxy Is 'Now Approved, Available This July'",2018-05-23 11:16:00-04:00,TXMD,positive
1277930.0,"Benzinga's Daily Biotech Pulse: Portola Receives FDA Nod, Mallinckrodt Gets Thumbs Down",2018-05-04 08:16:00-04:00,TXMD,neutral
1277931.0,"TherapeuticsMD Q1 EPS $(0.11) Misses $(0.10) Estimate, Sales $3.773M Miss $4.19M Estimate",2018-05-03 17:11:00-04:00,TXMD,negative
1277932.0,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Action Dates,2018-05-01 15:39:00-04:00,TXMD,neutral
1277933.0,"Adam Feuerstein @adamfeuerstein Tweet; $TXMD is really good at acting shamelessly, like with this totally unnecessary press release.",2018-04-11 06:13:00-04:00,TXMD,positive
1277934.0,TherapeuticsMD Enters Into Label Negotiations for TX-004HR With The FDA,2018-04-11 06:02:00-04:00,TXMD,neutral
1277935.0,TherapeuticsMD Enters Into Label Negotiations with FDA for TX-004HR,2018-04-11 06:01:00-04:00,TXMD,neutral
1277936.0,26 Stocks Moving In Friday's Pre-Market Session,2018-03-09 08:07:00-05:00,TXMD,neutral
1277937.0,"TherapeuticsMD Announces FDA Acceptance of New Drug Application For TX-001HR, Announces PDUFA Date For Oct. 28th 2018",2018-03-08 16:25:00-05:00,TXMD,positive
1277938.0,TherapeuticsMD Shares Up 4.7% Wed. Despite Q4 Miss Reported Tues. Afternoon,2018-02-21 11:36:00-05:00,TXMD,positive
1277939.0,"TherapeuticsMD Reports Q4 EPS $(0.10) vs $(0.09) Est., Sales $4.124M vs $4.66M Est.",2018-02-20 16:07:00-05:00,TXMD,neutral
1277940.0,TherapeuticsMD Q4 Earnings Preview,2018-02-20 12:09:00-05:00,TXMD,neutral
1277941.0,"TherapeuticsMD Submits NDA For VMS Candidate, Shares Rise",2017-12-29 12:42:00-05:00,TXMD,positive
1277942.0,26 Stocks Moving In Friday's Mid-Day Session,2017-12-29 12:36:00-05:00,TXMD,neutral
1277943.0,22 Stocks Moving In Friday's Pre-Market Session,2017-12-29 08:20:00-05:00,TXMD,neutral
1277944.0,A Peek Into The Markets: U.S. Stock Futures Surge On Last Trading Day Of 2017,2017-12-29 07:49:00-05:00,TXMD,neutral
1277945.0,"5 Stocks To Watch For December 29, 2017",2017-12-29 04:10:00-05:00,TXMD,neutral
1277946.0,TherapeuticsMD Announces Submission of New Drug Application for TX-001HR To The FDA,2017-12-28 16:30:00-05:00,TXMD,neutral
1277947.0,28 Stocks Moving In Wednesday's Pre-Market Session,2017-12-20 08:12:00-05:00,TXMD,neutral
1277948.0,"TherapeuticsMD Announces FDA Accepts NDA For TX-004HR, Sets PDUFA Date May 29, 2018",2017-12-19 16:36:00-05:00,TXMD,positive
1277949.0,TherapeuticsMD Option Alert: Jan 19 $6 Puts at the Bid: 2000 @ $0.3 vs 3202 OI; Ref=$6.62,2017-12-18 09:38:00-05:00,TXMD,positive
1277950.0,TherapeuticsMD Reports Resubmission Of NDA For TX-004HR,2017-11-29 16:32:00-05:00,TXMD,neutral
1277951.0,Therapeutics MD Option Alert: Dec 15 $6 Calls Sweep (20) at the Ask: 975 @ $0.448 vs 3968 OI; Ref=$6.04,2017-11-24 09:45:00-05:00,TXMD,positive
1277952.0,"Jefferies 2017 London Healthcare Conference Concludes Today, Presenters Include: Ignyta, Heron Therapeutics, and TherapeuticsMD",2017-11-16 09:28:00-05:00,TXMD,neutral
1277953.0,"Stifel 2017 Healthcare Conference Begins Today, Presenters Include: Seres Therapeutics, Verastem, TherapeuticsMD, Aerie Pharmaceuticals, Mednax, Celgene, TransEnterix, Exelixis, Tandem Diabetes Care and Masimo",2017-11-14 09:36:00-05:00,TXMD,positive
1277954.0,40 Stocks Moving In Tuesday's Pre-Market Session,2017-11-07 08:07:00-05:00,TXMD,neutral
1277955.0,40 Biggest Movers From Yesterday,2017-11-07 04:50:00-05:00,TXMD,neutral
1277956.0,Mid-Afternoon Market Update: Crude Oil Up 2.5%; Henry Schein Shares Fall On Earnings Miss,2017-11-06 14:32:00-05:00,TXMD,negative
1277957.0,"Oppenheimer Out Positive On TherapeuticsMD, Says They See A Favorable Setup For Shares; Reiterates Outperform Rating and $10 PT",2017-11-06 13:07:00-05:00,TXMD,positive
1277958.0,"TherapeuticsMD Up 40% After Mixed Q3, Plans To Resubmit NDA For TX-004HR",2017-11-06 12:47:00-05:00,TXMD,neutral
1277959.0,31 Stocks Moving In Monday's Mid-Day Session,2017-11-06 12:45:00-05:00,TXMD,neutral
1277960.0,Mid-Day Market Update: Mesa Laboratories Drops After Q2 Results; TherapeuticsMD Shares Jump,2017-11-06 12:03:00-05:00,TXMD,positive
1277961.0,"TherapeuticsMD Shares Up 45% Into Last Hour Of Mon.-Morning Trade; Hearing Cowen Analyst Boosted Price Target On Stock From $13 To $16, Maintained Buy; BZ NOTE: New Target Represents Possible Upside Of ~155%",2017-11-06 11:06:00-05:00,TXMD,positive
1277962.0,Mid-Morning Market Update: Markets Edge Higher; CVS Health Earnings Top Estimates,2017-11-06 10:13:00-05:00,TXMD,positive
1277963.0,Adam Feuerstein Tweets: $NVO sales of women's hormone therapies (including Vagifem) -54% this year due to generic competition. This is $TXMD future.,2017-11-06 10:08:00-05:00,TXMD,neutral
1277964.0,30 Stocks Moving In Monday's Pre-Market Session,2017-11-06 08:06:00-05:00,TXMD,neutral
1277965.0,TherapeuticsMD Shares Now Up 39.9% Premarket Following News Co. To Resubmit NDA For TX-004HR; Stock Well Off Pre-Market High Of ~$9.50,2017-11-06 07:29:00-05:00,TXMD,positive
1277966.0,TherapeuticsMD +117% Premarket @ $9.46; Co Announced Plan to Resubmit the NDA for TX-004HR,2017-11-06 06:20:00-05:00,TXMD,neutral
1277967.0,"TherapeuticsMD Reports Q3 EPS $(0.07) vs $(0.11) Est., Sales $4.41M vs $5.22M Est.",2017-11-06 06:05:00-05:00,TXMD,neutral
1277968.0,TherapeuticsMD Reports Plan to Resubmit the New Drug Application for TX-004HR,2017-11-06 06:00:00-05:00,TXMD,neutral
1277969.0,Therapeutics MD Option Alert: Nov 17 $5 Calls Sweep (24) at the Ask: 1020 @ $0.598 vs 6548 OI; Ref=$4.61,2017-11-01 11:55:00-04:00,TXMD,positive
1277970.0,Watch These 8 Huge Call Purchases In Wednesday Trade,2017-10-11 04:19:00-04:00,TXMD,positive
1277971.0,Benzinga's Option Alert Recap From October 10,2017-10-10 16:35:00-04:00,TXMD,positive
1277972.0,TherapeuticsMD Option Alert: Nov 17 $4 Calls Sweep (21) at the Ask: 500 @ $1.25 vs 35 OI; Ref=$4.88,2017-10-10 15:19:00-04:00,TXMD,positive
1277973.0,15 Biggest Mid-Day Losers For Tuesday,2017-09-26 13:04:00-04:00,TXMD,negative
1277974.0,"Cantor Fitzgerald Global Healthcare Conference Continues Today, Presenters Include:  Innoviva, Puma Biotech, Magellan Health, TherapeuticsMD, Zoetis, Aurinia Pharma and Celgene",2017-09-26 08:36:00-04:00,TXMD,neutral
1277975.0,22 Stocks Moving In Tuesday's Pre-Market Session,2017-09-26 08:10:00-04:00,TXMD,neutral
1277976.0,TherapeuticsMD Prices 12.4M Share Offering @$5.65/Share,2017-09-26 04:36:00-04:00,TXMD,positive
1277977.0,TherapeuticsMD Announces 12.4M Share Offering Common Stock,2017-09-25 16:52:00-04:00,TXMD,positive
1277978.0,TherapeuticsMD to move its Listing from NYSE to NASDAQ,2017-09-25 06:49:00-04:00,TXMD,neutral
1277979.0,"TherapeuticsMD Announces Submission Of Add'l Safety Information For TX-004HR NDA, Scheduled Meeting With FDA For 11/3/17; Co. Expects To Learn Then If Add'l Data Addresses Concerns In Previously Issued CRL",2017-09-14 16:32:00-04:00,TXMD,positive
1277980.0,"Morgan Stanley Healthcare Conference Concludes Today, Presenters Include Ironwood Pharmaceuticals, Sage Therapeutics, Pfizer, TherapeuticsMD, Alnylam, bluebird bio, and Cigna",2017-09-13 09:24:00-04:00,TXMD,neutral
1277981.0,22 Biggest Mid-Day Losers For Friday,2017-09-08 13:39:00-04:00,TXMD,negative
1277982.0,"Benzinga's Top Upgrades, Downgrades For September 8, 2017",2017-09-08 09:20:00-04:00,TXMD,positive
1277983.0,"Morgan Stanley Initiates Coverage On TherapeuticsMD with Equal-Weight Rating, Announces $6.00 Price Target",2017-09-08 06:24:00-04:00,TXMD,neutral
1277984.0,"TherapeuticsMD Issues Regulatory Update On TX-004HR: Co. Received Formal General Advice Letter From FDA Stating Initial Review Of Info Has Been Completed, Is Requesting Co. Submit Added Endometrial Safety Info To NDA",2017-08-10 16:29:00-04:00,TXMD,positive
1277985.0,"TherapeuticsMD Reports Q2 EPS $(0.10) vs $(0.11) Est., Sales $4.3M vs $4.9M Est.",2017-08-03 17:09:00-04:00,TXMD,neutral
1277986.0,15 Biggest Mid-Day Gainers For Friday,2017-07-21 12:22:00-04:00,TXMD,neutral
1277987.0,"Benzinga's Top Upgrades, Downgrades For July 21, 2017",2017-07-21 09:27:00-04:00,TXMD,positive
1277988.0,"TherapeuticsMD Shares Up 6% Pre-Market Following Deutsche Bank Initiation At Buy, Price Target Which Suggests Possible Upside Of 75%",2017-07-21 08:56:00-04:00,TXMD,positive
1277989.0,"Deutsche Bank Initiates Coverage On TherapeuticsMD with Buy Rating, Announces $10.00 Price Target",2017-07-21 07:26:00-04:00,TXMD,neutral
1277990.0,Mid-Afternoon Market Update: Peregrine Pharma Drops After Q4 Results; Quidel Shares Jump,2017-07-17 14:30:00-04:00,TXMD,positive
1277991.0,"Cantor On TherapeuticsMD TX-004 Update: Overweight Rating Reiterated, Firm's Bill Tanner Highlights '...FDA...could be comfortable with the conduct of a long-term safety study as part of a post-approval comittment'",2017-07-17 13:22:00-04:00,TXMD,positive
1277992.0,12 Biggest Mid-Day Losers For Monday,2017-07-17 12:55:00-04:00,TXMD,negative
1277993.0,Mid-Day Market Update: Sevcon Surges Following Acquisition News; TherapeuticsMD Shares Slide,2017-07-17 12:02:00-04:00,TXMD,positive
1277994.0,TherapeuticsMD Shares Down 11% Following Cautious-Sounding TX-004HR Regulatory Update,2017-07-17 10:20:00-04:00,TXMD,positive
1277995.0,Mid-Morning Market Update: Markets Edge Higher; BlackRock Profit Misses Views,2017-07-17 10:11:00-04:00,TXMD,positive
1277996.0,20 Stocks Moving In Monday's Pre-Market Session,2017-07-17 08:19:00-04:00,TXMD,neutral
1277997.0,STAT News' Adam Feuerstein Tweets: $TXMD Regulatory update on resolving the TX-004 complete response letter does not read well at all.,2017-07-17 07:18:00-04:00,TXMD,positive
1277998.0,TherapeuticsMD Gives Update on FDA Meeting Regarding TX-004HR,2017-07-17 06:59:00-04:00,TXMD,neutral
1277999.0,TherapeuticsMD Drops to Low of $4.91 on Volume,2017-07-11 13:19:00-04:00,TXMD,negative
1278000.0,12 Biggest Mid-Day Gainers For Tuesday,2017-07-11 12:24:00-04:00,TXMD,neutral
1278001.0,Oppenheimer Upgrades TherapeuticsMD to Outperform,2017-07-11 09:10:00-04:00,TXMD,neutral
1278002.0,Watch These 5 Huge Call Purchases In Friday Trade,2017-07-07 04:09:00-04:00,TXMD,positive
1278003.0,Benzinga's Option Alert Recap From July 6,2017-07-06 16:12:00-04:00,TXMD,positive
1278004.0,Option Alert: TherapeuticsMD Jul 7.5 Calls Sweep: 604 @  ASK  $0.15: 804 traded vs 4804 OI:  Earnings 8/3 After Close (est)  $5.29 Ref,2017-07-06 11:12:00-04:00,TXMD,positive
1278005.0,Benzinga's Option Alert Recap From June 22,2017-06-22 16:11:00-04:00,TXMD,positive
1278006.0,Therapeutics MD  Dec 7.5 Calls: 1104 @  ASK  $1.10: 1596 traded vs 2388 OI:  Earnings 8/3 After Close (est)  $5.90 Ref,2017-06-22 11:09:00-04:00,TXMD,neutral
1278007.0,Benzinga's Option Alert Recap From June 21,2017-06-21 16:08:00-04:00,TXMD,positive
1278008.0,Option Alert: Therapeutics MD Jul 7.5 Calls Sweep: 501 @  ASK  $0.25: 615 traded vs 2572 OI:  Earnings 8/3 After Close (est)  $5.67 Ref,2017-06-21 14:26:00-04:00,TXMD,positive
1278009.0,"TherapeuticsMD Up 19.4% Premarket, Jefferies Says They Understand The FDA Meeting Was Positive, Productive, And Accommodating Suggesting That The 52-Week Post-Marketing Study May Address The Sole Noted CRL Deficiency Of LT Safety",2017-06-19 08:27:00-04:00,TXMD,positive
1278010.0,22 Stocks Moving In Friday's Pre-Market Session,2017-06-16 08:28:00-04:00,TXMD,neutral
1278011.0,"Jefferies Health Care Conference Continues Today, Presenters Include: Ligand, Immunogen, TherapeuticsMD, Synergy Pharma, Ironwood, Acadia, Community Health Systems, & Celldex",2017-06-08 08:37:00-04:00,TXMD,positive
1278012.0,Tracking The Busy June PDUFA Calendar,2017-05-30 08:58:00-04:00,TXMD,neutral
1278013.0,Volume Spike in Therapeutics MD,2017-05-25 09:48:00-04:00,TXMD,neutral
1278014.0,"Bank Of America Health Care Conference Begins Today; Presenters Include Luminex, Acadia Healthcare, Express Scripts, Puma Biotech, Ultragenyx Pharma, Alexion, Medicines Co., Juno, TherapeuticsMD, & Seattle Genetics",2017-05-16 08:32:00-04:00,TXMD,positive
1278015.0,FDA Expresses Concern On TherapeuticsMD; Oppenheimer Downgrades,2017-05-09 13:49:00-04:00,TXMD,neutral
1278016.0,"Benzinga's Top Upgrades, Downgrades For May 9, 2017",2017-05-09 09:27:00-04:00,TXMD,positive
1278017.0,Analyst: The Nature Of TherapeuticsMD 's CRL From The FDA Is A 'Best-Case Scenario',2017-05-09 09:20:00-04:00,TXMD,neutral
1278018.0,Oppenheimer Downgrades TherapeuticsMD to Perform,2017-05-09 06:39:00-04:00,TXMD,neutral
1278019.0,Mid-Afternoon Market Update: Petmed Rises On Strong Q1 Results; TherapeuticsMD Shares Plunge,2017-05-08 14:34:00-04:00,TXMD,positive
1278020.0,12 Biggest Mid-Day Losers For Monday,2017-05-08 12:40:00-04:00,TXMD,negative
1278021.0,Mid-Day Market Update: Horizon Pharma Drops After Q1 Miss; SGOCO Group Shares Surge,2017-05-08 12:07:00-04:00,TXMD,positive
1278022.0,Mid-Morning Market Update: Markets Edge Lower; Tyson Profit Misses Estimates,2017-05-08 10:09:00-04:00,TXMD,negative
1278023.0,TherapeuticsMD Results 'Worse Than Expected',2017-05-08 08:45:00-04:00,TXMD,negative
1278024.0,Watch These 8 Huge Call Purchases In Monday Trade,2017-05-08 04:09:00-04:00,TXMD,positive
1278025.0,Will TherapeuticsMD's Yuvvexy Pass The FDA Muster?,2017-05-07 14:29:00-04:00,TXMD,neutral
1278026.0,Benzinga's Option Alert Recap From May 5,2017-05-05 16:16:00-04:00,TXMD,positive
1278027.0,Option Alert: TherapeuticsMD Jun 7.5 Calls Sweep: 500 @  ASK  $0.30: 813 traded vs 11k OI:  Earnings 8/3 After Close [est]  $4.71 Ref,2017-05-05 15:16:00-04:00,TXMD,positive
1278028.0,Option Alert: TherapeuticsMD May 5.0 Calls Sweep: 500 @  ASK  $0.65: 730 traded vs 4671 OI:  Earnings 8/3 After Close [est]  $4.69 Ref,2017-05-05 15:14:00-04:00,TXMD,positive
1278029.0,Benzinga's Option Alert Recap From May 2,2017-05-02 16:55:00-04:00,TXMD,positive
1278030.0,"TherapeuticsMD Reports Q1 EPS $(0.11) vs $(0.11) Est., Sales $4M vs $5.2M Est.",2017-05-02 16:54:00-04:00,TXMD,neutral
1278031.0,Option Alert: Therapeutics MD May 5.0 Puts Sweep: 1441 @  ASK  $0.85: 1447 traded vs 1174 OI:  Earnings 5/9 Before Open [est]  $4.61 Ref,2017-05-02 09:46:00-04:00,TXMD,positive
1278032.0,Tesla Takes The Lead In This Week's Hot Short-Selling Ideas,2017-04-26 09:50:00-04:00,TXMD,neutral
1278033.0,Mark Your Calendar For These Days In May To Play The Volatility Around FDA Decision Dates,2017-04-25 13:44:00-04:00,TXMD,positive
1278034.0,Adam Feuerstein Tweets: $TXMD Hormone Pill Faces Looming FDA Rejection and a Hostile Commercial Market —> thestreet.com/story/14096390…,2017-04-21 08:29:00-04:00,TXMD,negative
1278035.0,The Bull-Bear Debate In Therapeutics Rages From Research Notes To Twitter,2017-04-20 09:24:00-04:00,TXMD,negative
1278036.0,Adam Feuerstein Tweets: $TXMD all but confirms FDA rejection of TX-004HR expected on May 7,2017-04-19 09:44:00-04:00,TXMD,negative
1278037.0,TherapeuticsMD Issues Added Info on TX-004HR Regulatory Update: Sees FDA Finalizing Action on NDA on or Before Originally Scheduled PDUFA Target Action Date of May 7,2017-04-19 06:46:00-04:00,TXMD,neutral
1278038.0,Looking For The Positives In TherapeuticsMD's Recently Received FDA Letter,2017-04-11 14:06:00-04:00,TXMD,positive
1278039.0,20 Stocks Moving In Tuesday's Pre-Market Session,2017-04-11 09:27:00-04:00,TXMD,neutral
1278040.0,10 Biggest Mid-Day Losers For Monday,2017-04-10 14:26:00-04:00,TXMD,negative
1278041.0,"Hearing Cowen Defending TherapeuticsMD, Says This Will Be A Minor Delay At Worst And Provides No Change To Thesis",2017-04-10 13:52:00-04:00,TXMD,negative
1278042.0,FDA Says It Has Found Deficiencies That Preclude Discussion Of Labeling and Postmarketing Commitments Of TherapeuticsMD's TX-004HR At This Time,2017-04-10 08:04:00-04:00,TXMD,positive
1278043.0,18 Biggest Mid-Day Gainers For Wednesday,2017-04-05 12:55:00-04:00,TXMD,neutral
1278044.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-04-05 08:12:00-04:00,TXMD,neutral
1278045.0,TherapeuticsMD +11.6% Premarket @ $8.50; Co Announced Positive Phase 3 Data on TX-001HR in Presentations at ENDO 2017,2017-04-05 06:52:00-04:00,TXMD,positive
1278046.0,Benzinga's Option Alert Recap From April 4,2017-04-04 16:46:00-04:00,TXMD,positive
1278047.0,18 Biggest Mid-Day Gainers For Tuesday,2017-04-04 12:38:00-04:00,TXMD,neutral
1278048.0,Option Alert: TherpeuticsMD Jun 10.0 Puts Sweep: 500 @  ASK  $2.80: 540 traded vs 155 OI:  Earnings 5/2 Before Open (est)  $7.86 Ref,2017-04-04 11:06:00-04:00,TXMD,positive
1278049.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-04-04 08:16:00-04:00,TXMD,neutral
1278050.0,Volume Spike in TherapeuticsMD,2017-03-31 09:48:00-04:00,TXMD,neutral
1278051.0,"Oppenheimer Annual Healthcare Conference Concludes Today; Presenters Include HCA, Axovant, Zynerba, Aquinox Pharma, TherapeuticsMD, Humana, Endologix",2017-03-22 09:16:00-04:00,TXMD,neutral
1278052.0,"TherapeuticsMD Q4 EPS $(0.12) vs $(0.12) Est, Revenue $4.49M vs $5.91M Est",2017-02-23 06:46:00-05:00,TXMD,neutral
1278053.0,15 Stocks With The Highest Forecast Sales Growth,2016-12-23 13:56:00-05:00,TXMD,positive
1278054.0,"Cantor Fitzgerald Initiates Coverage On TherapeuticsMD at Overweight, Announces $34.00 Target",2016-12-16 09:04:00-05:00,TXMD,negative
1278055.0,"TherapeuticsMD Shares Lower For 2nd Day In A Row, Down 5.86 % Mid-Morning On Heavy Volume",2016-12-08 10:58:00-05:00,TXMD,neutral
1278056.0,"TherapeuticsMD Shares Down 4.31% On Heavy Volume Mid-Morning, Despite Favorable Commentary During CEO's Tuesday Night Appearance On CNBC's Mad Money",2016-12-07 11:13:00-05:00,TXMD,negative
1278057.0,18 Biggest Mid-Day Gainers For Tuesday,2016-12-06 12:23:00-05:00,TXMD,neutral
1278058.0,TherapeuticsMD Shares Unaffected as Traders Passing Around Word Co. Exec Will Be on Jim Cramer's 'Mad Money' Tonight,2016-12-06 11:11:00-05:00,TXMD,negative
1278059.0,18 Stocks Moving In Tuesday's Pre-Market Session,2016-12-06 08:25:00-05:00,TXMD,neutral
1278060.0,"TherapeuticsMD Announces Positive Top-Line Results from Pivotal Phase 3 Replenish Trial in Postmenopausal Women, Met All Co-Primary Efficacy and Safety Endpoints At Multiple Doses",2016-12-05 16:06:00-05:00,TXMD,positive
1278061.0,18 Stocks Moving In Monday's Pre-Market Session,2016-12-05 08:29:00-05:00,TXMD,neutral
1278062.0,TherapeuticsMD Shares Down 16.6%; Traders Attributing Downside to Negative Mention by Lakewood's Anthony Bozza at the Robin Hood Conference,2016-11-29 10:57:00-05:00,TXMD,negative
1278063.0,Option Alert: TXMD Jan17 7.5 Calls Sweep: 500 @  ASK  $0.85: 900 traded vs 1439 OI:  Earnings 2/23 After Close (est)  $5.60 Ref,2016-11-29 09:46:00-05:00,TXMD,positive
1278064.0,Watch These 5 Huge Put Purchases In Wednesday Trade,2016-11-23 02:00:00-05:00,TXMD,positive
1278065.0,Option Alert: TXMD Jan17 5.0 Puts Sweep: 500 @  ASK  $0.60: 1825 traded vs 10 OI:  Earnings 2/23 After Close (est)  $7.04 Ref,2016-11-22 13:16:00-05:00,TXMD,positive
1278066.0,Benzinga's Top Initiations,2016-11-22 12:04:00-05:00,TXMD,positive
1278067.0,"Oppenheimer Initiates Coverage On TherapeuticsMD, Inc. Common Stock at Outperform, Announces $12 Target",2016-11-22 08:37:00-05:00,TXMD,neutral
1278068.0,Option Alert: TXMD Nov16 7.5 Calls Sweep: 916 @  ASK  $0.15: 1000 traded vs 4987 OI:  Earnings 2/23 After Close (est)  $6.06 Ref,2016-11-09 13:35:00-05:00,TXMD,positive
1278069.0,"Guggenheim Assumes TherapeuticsMD, Inc. Common Stock at Buy",2016-11-07 06:49:00-05:00,TXMD,neutral
1278070.0,"TherapeuticsMD Reports Q3 EPS $(0.13) vs. Est. $(0.11), Rev. $5.5M vs. Est. $5.7M",2016-11-03 17:30:00-04:00,TXMD,neutral
1278071.0,Watch These 7 Huge Call Purchases In Wednesday Trade,2016-10-19 03:08:00-04:00,TXMD,positive
1278072.0,Option Alert: TXMD Dec16 7.5 Calls: 1600 @  Above Ask!  $0.75: 2000 traded vs 6958 OI:  Earnings 11/2  $6.23 Ref,2016-10-18 10:24:00-04:00,TXMD,positive
1278073.0,"UPDATE: TherapeuticsMD Sets PDUFA Target Action Date as May 7, '17",2016-09-19 16:30:00-04:00,TXMD,neutral
1278074.0,TherapeuticsMD Reports FDA Acceptance of NDA for PDUFA Data for Yuvvexy,2016-09-19 16:30:00-04:00,TXMD,positive
1278075.0,Option Alert: TXMD Oct16 7.5 Calls: 900 @  ASK  $0.55: 1440 traded vs 575 OI: $6.90 Ref,2016-08-26 15:56:00-04:00,TXMD,positive
1278076.0,"TherapeuticsMD, Inc. Reports Q2 EPS $(0.11) vs. Est. $(0.10), Rev. $4.4M vs. Est. $5.6M",2016-08-04 17:22:00-04:00,TXMD,neutral
1278077.0,TherapeuticsMD Reports NDA Submission for TX-004HR,2016-07-07 16:55:00-04:00,TXMD,neutral
1278078.0,"TherapeuticsMD Announces Filing For Yuvvexy, To Be Submitted By July 15",2016-06-29 16:51:00-04:00,TXMD,neutral
1278079.0,TherapeuticsMD Makes Innovation In Compliance Packaging For Its Prenatal Vitamins,2016-06-06 07:23:00-04:00,TXMD,positive
1278080.0,TherapeuticsMD Announces New Innovation in Compliance Packaging for Prenatal Vitamins,2016-06-06 06:07:00-04:00,TXMD,positive
1278081.0,TherapeuticsMD Presents Poster at ACOG 2016 with Additional Secondary Endpoint Data from Phase 3 Rejoice Trial,2016-05-15 06:45:00-04:00,TXMD,positive
1278082.0,Therapeutics MD Releases Investor Presentation,2016-05-04 06:22:00-04:00,TXMD,neutral
1278083.0,"Goldman Believes TherapeuticsMD Is 'Revitalizing Women's Health,' Initiates With Buy",2016-04-04 15:12:00-04:00,TXMD,neutral
1278084.0,Benzinga's Top Initiations,2016-04-04 09:47:00-04:00,TXMD,positive
1278085.0,"Goldman Sachs Initiates Coverage on TherapeuticsMD at Buy, Announces $10.00 PT",2016-04-04 05:52:00-04:00,TXMD,neutral
1278086.0,TherapeuticsMD Chief Clinical Officer Says  Rejoice Trial Data Demonstrated Clinically Meaningful Improvements for Postmenopausal Women Suffering from Symptoms of VVA,2016-04-02 16:24:00-04:00,TXMD,positive
1278087.0,"Therapeutics Reports Q4 EPS $(0.10) vs. Est. $(0.10), Rev. $5.629M vs. Est. $5.33M",2016-02-25 16:05:00-05:00,TXMD,neutral
1278088.0,T Rowe Price Reports 5.8% Passive Stake in TherapeuticsMD in 13G,2016-02-12 13:06:00-05:00,TXMD,positive
1278089.0,Therapeutics MD Spikes to High of $7; May be Attributed to Positive CNBC Mention,2016-02-04 13:49:00-05:00,TXMD,positive
1278090.0,TherapeuticsMD Shares Turn Positive in Premarket; Co Priced $125M Offering at $8.25/Share,2016-01-07 08:50:00-05:00,TXMD,positive
1278091.0,TherapeuticsMD Prices $125M Offering at $8.25/Share,2016-01-07 06:46:00-05:00,TXMD,neutral
1278092.0,Jefferies' Best Biotech Ideas For 2016 (And Beyond),2016-01-06 15:52:00-05:00,TXMD,positive
1278093.0,"TherapeuticsMD Plans On Raising $125 Million To Fund Commercialization Activities, Research & Clinical Trials",2016-01-06 08:19:00-05:00,TXMD,neutral
1278094.0,TherapeuticsMD Announces $125M Offering of Common Stock,2016-01-05 16:02:00-05:00,TXMD,neutral
1278095.0,Therapeutics Reports $125M Offering,2016-01-05 16:01:00-05:00,TXMD,neutral
1278096.0,Option Alert: TXMD Mar16 15.0 Calls Sweep: 1000 @  ASK  $0.70: 1000 traded vs 31 OI: $10.27 Ref,2015-12-23 10:55:00-05:00,TXMD,positive
1278097.0,Option Alert: TXMD Jan16 10.0 Calls Sweep: 507 @  ASK  $0.50: 531 traded vs 5950 OI: $8.65 Ref,2015-12-14 15:50:00-05:00,TXMD,positive
1278098.0,Mid-Afternoon Market Update: Dow Dips Over 150 Points; Childrens Place Shares Surge On Upbeat Earnings,2015-12-08 15:30:00-05:00,TXMD,positive
1278099.0,Mid-Day Market Update: United Natural Foods Drops On Earnings Miss; Fairchild Semiconductor Shares Jump,2015-12-08 12:55:00-05:00,TXMD,positive
1278100.0,Mid-Morning Market Update: Markets Tumble; AutoZone Profit Tops Estimates,2015-12-08 10:14:00-05:00,TXMD,positive
1278101.0,Morning Market Gainers,2015-12-08 09:46:00-05:00,TXMD,neutral
1278102.0,TherapeuticsMD +32% After-Hours @$8.75 After Co Announces Positive Top-Line Results from its Phase 3 Rejoice Trial in Postmenopausal Women,2015-12-07 16:19:00-05:00,TXMD,positive
1278103.0,"TherapeuticsMD Reports Positive Top-Line Results from its Phase 3 Rejoice Trial in Postmenopausal Women with Vulvar and Vaginal Atrophy Treated with 25 mcg, 10 mcg or 4 mcg of TX-004HR",2015-12-07 16:10:00-05:00,TXMD,positive
1278104.0,Option Alert: $TXMD Dec $7.5/$10 Call Spread; 700 Spreads; Ref $7.00,2015-11-12 11:57:00-05:00,TXMD,positive
1278105.0,"TherapeuticsMD Reports Q3 EPS $(0.11) vs $(0.12) Est., Sales $5.2M vs $5M Est.",2015-11-04 17:30:00-05:00,TXMD,neutral
1278106.0,TherapeuticsMD Completes Enrollment in Phase 3 Clinical Trial of Bio-identical Oral Combination of Estradiol and Progesterone Product Candidate,2015-10-13 07:34:00-04:00,TXMD,neutral
1278107.0,TherapeuticsMD Completes Enrollment in Phase 3 Clinical Trial of Bio-identical Oral Combination of Estradiol and Progesterone Product Candidate,2015-10-13 07:00:00-04:00,TXMD,neutral
1278108.0,Traders Attributing Recent Move Higher in TherapeuticsMD to Mid-Day Note from Jefferies Suggesting FDA Worksho Could Result in Black Box Warnings Being Removed,2015-10-01 12:49:00-04:00,TXMD,negative
1278109.0,TherapeuticMD Spikes to High on Volume,2015-08-11 10:23:00-04:00,TXMD,neutral
1278110.0,"TherapeuticsMD Reports Q2 EPS $(0.16) vs. Est. $(0.11), Rev. $4.8M vs. Est. $4.65M",2015-08-06 18:03:00-04:00,TXMD,neutral
1278111.0,TherapeuticsMD Prices 3.8M Share Offering @$7.80/Share,2015-07-10 03:26:00-04:00,TXMD,positive
1278112.0,TherapeuticsMD Reports Closing of Enrollment in REJOICE Trial for TX-004HR,2015-06-09 07:30:00-04:00,TXMD,positive
1278113.0,"Guggenheim Securities Initiates Coverage on TherapeuticsMD at Buy, Announces $30.00 PT",2015-06-08 16:58:00-04:00,TXMD,positive
1278114.0,"Guggenheim Initiates Coverage on Regulus Therapeutics, Kythera Biopharma, TherapeuticsMD with Buy Ratings",2015-06-08 16:57:00-04:00,TXMD,neutral
1278116.0,TherapeuticsMD Shares Rise 3%; May be Attributed in Part to Recent Insider Buying,2015-05-14 10:04:00-04:00,TXMD,positive
1278117.0,"TherapeuticsMD Director Russell Buys 35,000 Shares @$6.15/Share -Form 4",2015-05-13 16:36:00-04:00,TXMD,positive
1278118.0,TherapeuticsMD Earlier Reported Q1 Loss of $0.13/Share vs Loss of $0.10/Share Est.,2015-05-05 18:02:00-04:00,TXMD,negative
1278119.0,TherapeuticsMD Shares Rise 3% Premarket Following CEO Appearance on Mad Money With Jim Cramer,2015-04-02 08:05:00-04:00,TXMD,negative
1278120.0,"Finizio: 'Women Want Natural Hormones and they Don't Exist'; '10,000 Women/Day are Turning 65'",2015-04-01 18:41:00-04:00,TXMD,positive
1278121.0,TherapeuticsMD CEO Finizio: 'We've Only Raised About $200M Since We Started the Company',2015-04-01 18:40:00-04:00,TXMD,neutral
1278122.0,Jim Cramer Interviewing  CEO Robert G. Finizio of TherapeuticsMD on Mad Money,2015-04-01 18:36:00-04:00,TXMD,negative
1278123.0,TherapeuticsMD Shares Spike to High as CEO Robert G. Finizio to be Interviewed by Jim Cramer on Mad Money Tonight,2015-04-01 13:23:00-04:00,TXMD,negative
1278124.0,Hearing TherapeuticsMD on Mad Money Tonight,2015-04-01 12:25:00-04:00,TXMD,negative
1278125.0,TherapeuticsMD Reports Q4 Operating Loss of $0.10/Share vs Loss of $0.09/Share Est.,2015-03-10 16:09:00-04:00,TXMD,negative
1278126.0,Physicians' Visual Assessments Correlate with Objective Measurements of Postmenopausal VVA Patients Treated with TX-004HR VagiCap,2015-03-09 08:00:00-04:00,TXMD,neutral
1278127.0,TherapeuticsMD Prices 13.6M Shares at $4.05/Share,2015-02-11 08:02:00-05:00,TXMD,positive
1278128.0,TherapeuticsMD Announces Offering of Common Stock,2015-02-10 16:01:00-05:00,TXMD,neutral
1278129.0,S-3 Filing from TherapeuticsMD Shows Registration for $100M Mixed Securities Shelf Offering,2014-12-19 17:03:00-05:00,TXMD,positive
1278130.0,TherapeuticsMD Receives 5 New Patent Allowances,2014-12-15 16:20:00-05:00,TXMD,neutral
1278131.0,"Events for the Week of Nov. 17-21, 2014",2014-11-17 13:13:00-05:00,TXMD,neutral
1278132.0,TherapeuticsMD Announces Oral Presentation Of Positive Phase 2 And Bioavailability Data On TX-004HR (VagiCapTM),2014-10-15 16:32:00-04:00,TXMD,positive
1278133.0,TherapeuticsMD Wins Two New Patents,2014-09-30 17:01:00-04:00,TXMD,positive
1278134.0,TherapeuticsMD Begins Phase 3 Clinical Trial of TX-004HR ,2014-09-29 16:05:00-04:00,TXMD,neutral
1278135.0,TherapeuticsMD Prices 8.6M Share Offering At $4.67/Share,2014-07-30 07:03:00-04:00,TXMD,positive
1278136.0,TherapeuticsMD Shares Down 1.5% on $40M Offering,2014-07-29 16:44:00-04:00,TXMD,positive
1278137.0,TherapeuticsMD Shares Rally +27% On FBR's Initiation,2014-07-08 14:49:00-04:00,TXMD,positive
1278138.0,Morning Market Movers ,2014-07-08 09:37:00-04:00,TXMD,neutral
1278139.0,Benzinga's Top Initiations,2014-07-08 08:26:00-04:00,TXMD,positive
1278140.0,Benzinga's Top #PreMarket Gainers,2014-07-08 08:04:00-04:00,TXMD,positive
1278141.0,"FBR Capital Initiates TherapeuticsMD At Outperform, Shares Jump",2014-07-08 07:34:00-04:00,TXMD,positive
1278142.0,"UPDATE: TherapeuticsMD Shares Rise 25% on FBR Initiation at Outperform, $34 PT",2014-07-08 07:15:00-04:00,TXMD,positive
1278143.0,"FBR Capital Markets Initiates Coverage on TherapeuticsMD Trust at Outperform, Announces $34 Price Target",2014-07-08 06:39:00-04:00,TXMD,positive
1278144.0,"TherapeuticsMD Reports Q1 Loss of $0.06/Share, Sales $2.8M",2014-05-05 16:13:00-04:00,TXMD,negative
1278145.0,Sub $5 Stocks With Expected Return Of Over 50% In 2014: Investment Idea Of The Day,2014-04-16 15:42:00-04:00,TXMD,neutral
1278146.0,UPDATE: TherapeuticsMD Reports Positive Results of Rabbit Irritation Study for Its Estradiol Vaginal Capsule VagiCap™ (TX 004-HR) for Treatment of Vulvar Vaginal Atrophy (VVA),2014-04-07 16:09:00-04:00,TXMD,positive
1278147.0,TherapeuticsMD Announces Results of Rabbit Irritation Study for TX 004-HR for Treatment of VVA,2014-04-07 16:05:00-04:00,TXMD,neutral
1278148.0,"BocaGreenMD Launches Prena1 Pearl, Generic Version of vitaMedMD's vitaPearl",2014-04-07 07:16:00-04:00,TXMD,neutral
1278149.0,TherapeuticsMD Prices 9M Shares at $7.10/Share,2014-03-20 17:36:00-04:00,TXMD,positive
1278150.0,"Afternoon Movers for Wednesday, March 19th 2014",2014-03-19 15:54:00-04:00,TXMD,neutral
1278151.0,UPDATE: TheraputicsMD Announces Launch of Secondary Offering of 9M Common Shares,2014-03-18 16:03:00-04:00,TXMD,positive
1278152.0,TheraputicsMD Announces Launch of Secondary Offering of 9M Common Shares,2014-03-18 16:03:00-04:00,TXMD,positive
1278153.0,"TherapeuticsMD Reports Q4 Loss of $0.06/Share, Sales $2.9M",2014-03-03 16:09:00-05:00,TXMD,negative
1278154.0,TherapeuticsMD Falls on StreetSweeper Report,2014-02-14 10:17:00-05:00,TXMD,neutral
1278155.0,TherapeuticsMD Reports Positive PK Study Results for Estradiol Vaginal Capsule VagiCap for Treatment of VVA,2014-01-28 07:12:00-05:00,TXMD,positive
1278156.0,TherapeuticsMD Initiates Phase 3 Clinical Trial of TX 12-002-HR for Treatment of Secondary Amenorrhea ,2014-01-24 07:05:00-05:00,TXMD,positive
1278157.0,"TherapeuticsMD Announces Issuance of U.S. Patent Covering Natural Combination Hormone Replacement Formulations and Therapies, Including TX 12-001-HR",2014-01-22 16:20:00-05:00,TXMD,positive
1278158.0,"Shares of TherapeuticsMD Up 10% to Over $5.50 Level Following Noble Financial Report Suggesting Co. 'Advancing ""First-in-Class"" and ""Potential Best-in-Class"" Pipeline",2014-01-10 15:24:00-05:00,TXMD,positive
1278159.0,TherapeuticsMD Receives Notice of Allowance for Patent Covering TX 12-001-HR,2013-12-09 07:35:00-05:00,TXMD,positive
1278160.0,"TherapeuticsMD Names Joel S. Krasnow, M.D. as Chief Scientific Officer ",2013-12-04 07:08:00-05:00,TXMD,neutral
1278161.0,TherapeuticsMD Phase 1 Pilot Study Shows TX-12-004-HR Estradiol VagiCap Improves Conditions of Vulvar and Vaginal Atrophy (VVA) ,2013-10-22 08:10:00-04:00,TXMD,positive
1278162.0,Afternoon Market Losers,2013-07-01 13:53:00-04:00,TXMD,negative
1278163.0,TherapeuticsMD Added to 2013 Russell Indexes ,2013-07-01 08:02:00-04:00,TXMD,neutral
1278164.0,TherapeuticsMD Investigational New Drug Filing Accepted By FDA,2013-06-14 08:04:00-04:00,TXMD,positive
1278165.0,UPDATE: Jefferies Initiates TherapeuticsMD with Buy on New Hormone Replacement Products,2013-04-26 09:28:00-04:00,TXMD,neutral
